written on 30.05.2014
Tags:
,

FDA will hear Sanofi's second plea for Lemtrada approval

TAGS: ,

On Friday, the FDA accepted Sanofi's supplemental application for its once-rejected multiple sclerosis treatment Lemtrada for consideration, and a 6-month review period follows.

Latest Report